Cargando…

Comparison of the predictive performance of risk of malignancy indexes 1–4, HE4 and risk of malignancy algorithm in the triage of adnexal masses

OBJECTIVES: For patients presenting with adnexal mass, it is important to correctly distinguish whether the mass is benign or malignant for the purpose of precise and timely referral and implication of correct line of management. The objective of this study was to evaluate the performance of Risk of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hada, Abha, Han, Li-ping, Chen, Yanyan, Hu, Qing-hong, Yuan, Yidan, Liu, Liya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183707/ https://www.ncbi.nlm.nih.gov/pubmed/32334618 http://dx.doi.org/10.1186/s13048-020-00643-6

Ejemplares similares

Preoperative Evaluation of Risk of Ovarian Malignancy Algorithm Index in Prediction of Malignancy of Adnexal Masses
por: Farzaneh, Farah, et al.
Publicado: (2014)

Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses
por: Terlikowska, Katarzyna M., et al.
Publicado: (2016)

A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses
por: Anton, Cristina, et al.
Publicado: (2012)

The Comparison of Pelvic Mass Score and Risk of Malignancy Index-3 in Discrimination of Benign and Malignant Adnexal Masses
por: Isgandarova, Aliya, et al.
Publicado: (2020)

Adnexal mass with extremely high levels of CA-125 and CA19-9 but normal Human Epididymis Protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA): Endometriosis or ovarian malignancy? A case report
por: Khodaverdi, Sepideh, et al.
Publicado: (2018)

Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China
por: He, Ping, et al.
Publicado: (2021)

Performance of IOTA Simple Rules Risks, ADNEX Model, Subjective Assessment Compared to CA125 and HE4 with ROMA Algorithm in Discriminating between Benign, Borderline and Stage I Malignant Adnexal Lesions
por: Czekierdowski, Artur, et al.
Publicado: (2023)

Can Replacing CA125 with HE4 in Risk of Malignancy Indices 1–4 Improve Diagnostic Performance in the Presurgical Assessment of Adnexal Tumors?
por: Abdalla, Nabil, et al.
Publicado: (2017)

Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?
por: Abdalla, Nabil, et al.
Publicado: (2018)

Assessment of Diagnostic Value of Serum Ca-125 and Risk of Malignancy Index Scoring in the Evaluation of Adnexal Masses
por: Khoiwal, Kavita, et al.
Publicado: (2019)

Correlation of ultrasound features and the Risk of Ovarian Malignancy Algorithm score for different histopathological subtypes of benign adnexal masses
por: Ionescu, Crîngu Antoniu, et al.
Publicado: (2018)

Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2020)

Nomogram based on the O-RADS for predicting the malignancy risk of adnexal masses with complex ultrasound morphology
por: Gong, Li-Ping, et al.
Publicado: (2023)

Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods
por: Meys, E. M. J., et al.
Publicado: (2017)

A preliminary study: The sequential use of the risk malignancy index and contrast-enhanced ultrasonography in differential diagnosis of adnexal masses
por: Qiu, Li, et al.
Publicado: (2018)

The International Ovarian Tumor Analysis-Assessment of Different Neoplasias in the Adnexa (IOTA-ADNEX) Model Assessment for Risk of Ovarian Malignancy in Adnexal Masses
por: Cherukuri, Srinidhi, et al.
Publicado: (2022)

Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women
por: Cho, Hye Yon, et al.
Publicado: (2015)

The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4
por: Han, Kyung Hee, et al.
Publicado: (2019)

Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings
por: Wilailak, Sarikapan, et al.
Publicado: (2015)

Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial
por: Dochez, Vincent, et al.
Publicado: (2019)

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
por: Van Gorp, T, et al.
Publicado: (2011)

Early-Stage Ovarian Malignancy Score versus Risk of Malignancy Indices: Accuracy and Clinical Utility for Preoperative Diagnosis of Women with Adnexal Masses
por: Phinyo, Phichayut, et al.
Publicado: (2020)

Comparison of Ultrasound Scores in Differentiating between Benign and Malignant Adnexal Masses
por: Pelayo, Mar, et al.
Publicado: (2023)

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125
por: Chudecka-Głaz, Anita, et al.
Publicado: (2016)

Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses
por: Dewan, Rupali, et al.
Publicado: (2019)

Differences in perioperative outcomes after laparoscopic management of benign and malignant adnexal masses
por: Gad, Mohamad S., et al.
Publicado: (2011)

Predicting Malignancy in Adnexal Masses by the International Ovarian Tumor Analysis-Simple Rules
por: Solanki, Vrushti, et al.
Publicado: (2020)

Comparison of Ultrasound and Tumor Marker CA125 in Diagnosis of Adnexal Mass Malignancies
por: Behnamfar, Fariba, et al.
Publicado: (2022)

Diagnostic Performances of Ultrasound-Based Models for Predicting Malignancy in Patients with Adnexal Masses
por: Velayo, Clarissa L., et al.
Publicado: (2022)

Ultrasound Features and Ultrasound Scores in the Differentiation between Benign and Malignant Adnexal Masses
por: Pelayo, Mar, et al.
Publicado: (2023)

The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses
por: Dolgun, Zehra Nihal, et al.
Publicado: (2017)

Morphological parameters of ovarian masses and accuracy of the risk of malignancy index in diagnosing ovarian malignancy
por: Adilgereyeva, Akmaral S., et al.
Publicado: (2022)

Comparison of the Diagnostic Performances of Ultrasound-Based Models for Predicting Malignancy in Patients With Adnexal Masses
por: Qian, Le, et al.
Publicado: (2021)

Malignant epithelioid neoplasm of the ileum with ACTB-GLI1 fusion mimicking an adnexal mass
por: Marco, Ambrosio, et al.
Publicado: (2022)

The Contribution of Qualitative CEUS to the Determination of Malignancy in Adnexal Masses, Indeterminate on Conventional US – A Multicenter Study
por: Zhang, Xinling, et al.
Publicado: (2014)

Comparison of HE4, CA125, ROMA and CPH-I for Preoperative Assessment of Adnexal Tumors
por: Carreras-Dieguez, Núria, et al.
Publicado: (2022)

Performance of the IOTA ADNEX model combined with HE4 for identifying early-stage ovarian cancer
por: Yang, Suying, et al.
Publicado: (2022)

Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses
por: Pitta, Denise da Rocha, et al.
Publicado: (2013)

Is Risk Malignancy Index a Useful Tool for Predicting Malignant Ovarian Masses in Developing Countries?
por: Aziz, Aliya B., et al.
Publicado: (2015)

Adnexal Mass with Ascites and High Cancer Antigen -125 in a Young Female: Not Always Malignancy!
por: Chaudhary, Gyanendra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sfrgotk9u935u26nlsc7gnctaq